Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recasting and Book Reading Under Ideal (Dose-controlled) and Typical (Dose-variable) Conditions: The Role of Fidelity and Adherence in Production and Comprehension Outcomes for Children With DLD

NCT05099328 is registered in ClinicalTrials.gov with University of Delaware as lead sponsor.

NCT NCT05099328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05099328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recasting and Book Reading Under Ideal (Dose-controlled) and Typical (Dose-variable) Conditions: The Role of Fidelity and Adherence in Production and Comprehension Outcomes for Children With DLD
Lead sponsor
University of Delaware
Phase
Not applicable
Overall status
Completed
Start date
September 28, 2021
Completion date
April 20, 2026
Enrollment
137 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

developmental language disorder and language impairment